[1]
“Blood-borne biomarkers: CT-DNA ushers in a new era of cancer detection”, Int. J. Pharm. Sci. Drug Res., vol. 16, no. 5, pp. 905–911, Sep. 2024, doi: 10.25004/IJPSDR.2024.160518.